Relying upon the best-selling third edition of Stahl's Essential Psychopharmacology, Dr Stephen M. Stahl has revised chapters covering depression and bipolar disorder for this edition. Significantly revised and expanded it is essential for professionals treating depression and students needing a straight forward illustrated guide to drug mechanism and current research. It includes advances in neurobiology and recent clinical developments to explain with renewed clarity clinical advances in antidepressant therapy and includes new coverage of sleep disorders and disorders of impulse control. The fully revised text is complemented by many new illustrations and enhanced to reflect new knowledge and topics not covered in the previous edition. More than one-third longer than the previous edition, it is essential reading for professionals treating psychosis and students learning the mechanisms of drug reactions. Intended as a primer text covering all aspects of treatment for psychosis and related conditions, this concise volume can nevertheless be read cover to cover by experts and novices alike. Accreditation and Credit Designation Statements The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Neuroscience Education Institute designates this educational activity for a maximum of 90.0 AMA PRA Category 1 Credits(tm). Physicians should only claim credit commensurate with the extent of their participation in the activity. Sponsorship Information Sponsored by Neuroscience Education Institute Support This activity is supported solely by the sponsor. Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.

Relying upon the best-selling third edition of Stahl's Essential Psychopharmacology, Dr Stephen M. Stahl has revised chapters covering depression and bipolar disorder for this edition. Significantly revised and expanded it is essential for professionals treating depression and students needing a straight forward illustrated guide to drug mechanism and current research. It includes advances in neurobiology and recent clinical developments to explain with renewed clarity clinical advances in antidepressant therapy and includes new coverage of sleep disorders and disorders of impulse control. The fully revised text is complemented by many new illustrations and enhanced to reflect new knowledge and topics not covered in the previous edition. More than one-third longer than the previous edition, it is essential reading for professionals treating psychosis and students learning the mechanisms of drug reactions. Intended as a primer text covering all aspects of treatment for psychosis and related conditions, this concise volume can nevertheless be read cover to cover by experts and novices alike. Accreditation and Credit Designation Statements The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Neuroscience Education Institute designates this educational activity for a maximum of 90.0 AMA PRA Category 1 Credits(tm). Physicians should only claim credit commensurate with the extent of their participation in the activity. Sponsorship Information Sponsored by Neuroscience Education Institute Support This activity is supported solely by the sponsor. Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.